Literature DB >> 23677647

PLK2 modulates α-synuclein aggregation in yeast and mammalian cells.

Elisa Basso1, Pedro Antas, Zrinka Marijanovic, Susana Gonçalves, Sandra Tenreiro, Tiago Fleming Outeiro.   

Abstract

Phosphorylation of α-synuclein (aSyn) on serine 129 is one of the major post-translation modifications found in Lewy bodies, the typical pathological hallmark of Parkinson's disease. Here, we found that both PLK2 and PLK3 phosphorylate aSyn on serine 129 in yeast. However, only PLK2 increased aSyn cytotoxicity and the percentage of cells presenting cytoplasmic foci. Consistently, in mammalian cells, PLK2 induced aSyn phosphorylation on serine 129 and induced an increase in the size of the inclusions. Our study supports a role for PLK2 in the generation of aSyn inclusions by a mechanism that does not depend directly on serine 129 phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23677647     DOI: 10.1007/s12035-013-8473-z

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  34 in total

Review 1.  Milestones in PD genetics.

Authors:  Thomas Gasser; John Hardy; Yoshikuni Mizuno
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

2.  Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein.

Authors:  M Okochi; J Walter; A Koyama; S Nakajo; M Baba; T Iwatsubo; L Meijer; P J Kahle; C Haass
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

3.  Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease.

Authors:  K K Chung; Y Zhang; K L Lim; Y Tanaka; H Huang; J Gao; C A Ross; V L Dawson; T M Dawson
Journal:  Nat Med       Date:  2001-10       Impact factor: 53.440

4.  Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions.

Authors:  Masato Hasegawa; Hideo Fujiwara; Takashi Nonaka; Koichi Wakabayashi; Hitoshi Takahashi; Virginia M-Y Lee; John Q Trojanowski; David Mann; Takeshi Iwatsubo
Journal:  J Biol Chem       Date:  2002-10-10       Impact factor: 5.157

5.  Synphilin-1 is present in Lewy bodies in Parkinson's disease.

Authors:  K Wakabayashi; S Engelender; M Yoshimoto; S Tsuji; C A Ross; H Takahashi
Journal:  Ann Neurol       Date:  2000-04       Impact factor: 10.422

6.  Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease.

Authors:  John P Anderson; Donald E Walker; Jason M Goldstein; Rian de Laat; Kelly Banducci; Russell J Caccavello; Robin Barbour; Jiping Huang; Kristin Kling; Michael Lee; Linnea Diep; Pamela S Keim; Xiaofeng Shen; Tim Chataway; Michael G Schlossmacher; Peter Seubert; Dale Schenk; Sukanto Sinha; Wei Ping Gai; Tamie J Chilcote
Journal:  J Biol Chem       Date:  2006-07-17       Impact factor: 5.157

7.  Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of alpha-synuclein.

Authors:  Katerina E Paleologou; Adrian W Schmid; Carla C Rospigliosi; Hai-Young Kim; Gonzalo R Lamberto; Ross A Fredenburg; Peter T Lansbury; Claudio O Fernandez; David Eliezer; Markus Zweckstetter; Hilal A Lashuel
Journal:  J Biol Chem       Date:  2008-03-14       Impact factor: 5.157

8.  The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease.

Authors:  Oleg S Gorbatyuk; Shoudong Li; Layla F Sullivan; Weijun Chen; Galina Kondrikova; Fredric P Manfredsson; Ronald J Mandel; Nicholas Muzyczka
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-04       Impact factor: 11.205

9.  Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions.

Authors:  S Engelender; Z Kaminsky; X Guo; A H Sharp; R K Amaravi; J J Kleiderlein; R L Margolis; J C Troncoso; A A Lanahan; P F Worley; V L Dawson; T M Dawson; C A Ross
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

10.  Genome-wide association study reveals genetic risk underlying Parkinson's disease.

Authors:  Javier Simón-Sánchez; Claudia Schulte; Jose M Bras; Manu Sharma; J Raphael Gibbs; Daniela Berg; Coro Paisan-Ruiz; Peter Lichtner; Sonja W Scholz; Dena G Hernandez; Rejko Krüger; Monica Federoff; Christine Klein; Alison Goate; Joel Perlmutter; Michael Bonin; Michael A Nalls; Thomas Illig; Christian Gieger; Henry Houlden; Michael Steffens; Michael S Okun; Brad A Racette; Mark R Cookson; Kelly D Foote; Hubert H Fernandez; Bryan J Traynor; Stefan Schreiber; Sampath Arepalli; Ryan Zonozi; Katrina Gwinn; Marcel van der Brug; Grisel Lopez; Stephen J Chanock; Arthur Schatzkin; Yikyung Park; Albert Hollenbeck; Jianjun Gao; Xuemei Huang; Nick W Wood; Delia Lorenz; Günther Deuschl; Honglei Chen; Olaf Riess; John A Hardy; Andrew B Singleton; Thomas Gasser
Journal:  Nat Genet       Date:  2009-11-15       Impact factor: 38.330

View more
  15 in total

1.  From Yeast to Humans: Leveraging New Approaches in Yeast to Accelerate Discovery of Therapeutic Targets for Synucleinopathies.

Authors:  Jeff S Piotrowski; Daniel F Tardiff
Journal:  Methods Mol Biol       Date:  2019

2.  Interplay between sumoylation and phosphorylation for protection against α-synuclein inclusions.

Authors:  Hedieh Shahpasandzadeh; Blagovesta Popova; Alexandra Kleinknecht; Paul E Fraser; Tiago F Outeiro; Gerhard H Braus
Journal:  J Biol Chem       Date:  2014-09-17       Impact factor: 5.157

3.  Identifying Anti-prion Chemical Compounds Using a Newly Established Yeast High-Throughput Screening System.

Authors:  Zhiqiang Du; Stephanie Valtierra; Luzivette Robles Cardona; Sara Fernandez Dunne; Chi-Hao Luan; Liming Li
Journal:  Cell Chem Biol       Date:  2019-10-23       Impact factor: 8.116

Review 4.  The Interplay between Alpha-Synuclein Clearance and Spreading.

Authors:  Tomás Lopes da Fonseca; Anna Villar-Piqué; Tiago Fleming Outeiro
Journal:  Biomolecules       Date:  2015-04-14

Review 5.  Protein phosphorylation in neurodegeneration: friend or foe?

Authors:  Sandra Tenreiro; Katrin Eckermann; Tiago F Outeiro
Journal:  Front Mol Neurosci       Date:  2014-05-13       Impact factor: 5.639

6.  LK6/Mnk2a is a new kinase of alpha synuclein phosphorylation mediating neurodegeneration.

Authors:  Shiqing Zhang; Jiang Xie; Ying Xia; Shu Yu; Zhili Gu; Ruili Feng; Guanghong Luo; Dong Wang; Kai Wang; Meng Jiang; Xiao Cheng; Hai Huang; Wu Zhang; Tieqiao Wen
Journal:  Sci Rep       Date:  2015-07-29       Impact factor: 4.379

7.  Phosphorylation modulates clearance of alpha-synuclein inclusions in a yeast model of Parkinson's disease.

Authors:  Sandra Tenreiro; Madalena M Reimão-Pinto; Pedro Antas; José Rino; Donata Wawrzycka; Diana Macedo; Rita Rosado-Ramos; Triana Amen; Meytal Waiss; Filipa Magalhães; Andreia Gomes; Cláudia N Santos; Daniel Kaganovich; Tiago Fleming Outeiro
Journal:  PLoS Genet       Date:  2014-05-08       Impact factor: 5.917

8.  Novel AAV-based rat model of forebrain synucleinopathy shows extensive pathologies and progressive loss of cholinergic interneurons.

Authors:  Patrick Aldrin-Kirk; Marcus Davidsson; Staffan Holmqvist; Jia-Yi Li; Tomas Björklund
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

9.  DJ-1 interactions with α-synuclein attenuate aggregation and cellular toxicity in models of Parkinson's disease.

Authors:  L Zondler; L Miller-Fleming; M Repici; S Gonçalves; S Tenreiro; R Rosado-Ramos; C Betzer; K R Straatman; P H Jensen; F Giorgini; T F Outeiro
Journal:  Cell Death Dis       Date:  2014-07-24       Impact factor: 8.469

10.  miR-101-3p Contributes to α-Synuclein Aggregation in Neural Cells through the miR-101-3p/SKP1/PLK2 Pathway.

Authors:  Min Zhang; Wei Liu; Qingan Zhang; Hongfeng Hu
Journal:  J Healthc Eng       Date:  2021-06-12       Impact factor: 2.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.